Sabinsa Corporation announces that its popular dietary supplement ingredient ForsLean®, a standardized extract from Coleus forskholii roots patented by Sabinsa...Read More
Latest Press Releases
Sabinsa Publishes ForsLean® Safety Data in International Journal of Pharmacy & Pharmaceutical Research
January 19, 2016
Sabinsa Corporation and Sami Labs founder Dr. Muhammed Majeed was lead author of a paper published on the cumulative safety data of ForsLean®, the company’s.
Sabinsa Introduces Softgel Ready ForsLean® Soft Extracts Amid Exponential Growth In Coleus Demand: Company Cautions Against Low Quality Spam Knockoffs
July 8, 2014
Just in time for legitimate dietary supplement manufacturers to differentiate their products from the inferior spamtouted forskolin products driven by Dr. Oz and SPAM emails,.
Sabinsa Receives Payment from Creative Compounds for ForsLean® Trademark Infringement
July 10, 2012
An intellectual property battle lasting three years and reaching the US Supreme Court has ended at last with payment to Sabinsa Corporation by Creative Compounds.